TELA Bio to Participate in Upcoming Investor Conferences

Rhea-AI Summary

TELA Bio, a commercial-stage medical technology company, announced its participation in two investor conferences in August 2022. The management will present virtually at the Needham Med Tech & Diagnostics 1x1 Conference on August 15 and at the Canaccord Annual Growth Conference on August 11 at 2:00 PM ET. The company focuses on innovative soft-tissue reconstruction solutions, emphasizing patient anatomy preservation. Live webcasts of the presentations will be available on their official site.

MALVERN, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, today announced that it will participate in two upcoming investor conferences.

TELA Bio’s management will be participating virtually in the Needham Med Tech & Diagnostics 1x1 Conference on Monday, August 15^th, 2022.

TELA Bio’s management is also scheduled to present at the Canaccord Annual Growth Conference on Thursday, August 11^th, 2022, at 2:00pm ET. Interested parties can access the live and archived webcast at ir.telabio.com.

About TELA Bio, Inc.

TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient’s natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.

Investor Contact
Greg Chodaczek
332-895-3230
ir@telabio.com

FAQ

What are the upcoming investor conferences for TELA in August 2022?

TELA Bio will participate in the Needham Med Tech & Diagnostics 1x1 Conference on August 15 and the Canaccord Annual Growth Conference on August 11, 2022.

How can I access TELA Bio's conference presentations?

You can access the live and archived webcasts of TELA Bio's presentations on their official investor relations page.

What is TELA Bio's focus in the medical technology industry?

TELA Bio specializes in providing innovative soft-tissue reconstruction solutions that prioritize the preservation of the patient’s anatomy.

When is the Canaccord Annual Growth Conference where TELA will present?

The Canaccord Annual Growth Conference, where TELA will present, is scheduled for August 11, 2022, at 2:00 PM ET.